Plant Health Care looks to begin sales of peptide product following positive results from trials

Writer,

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

Plant Health Care said it planned to move forward with sales of its peptide product to combat the impact of Asian soybean rust, a potentially devastating disease that regularly affects soybean yields in Brazil, following positive results from trials.

In independent trials, carried out by PLANTEC, a major contract research organisation in Brazil, the company's REtec peptide PHC27 significantly improved Asian soybean rust control of foliar fungicide programmes, even in fields facing heavy disease pressure, Plant Health Care said.

'Disease control was improved by up to 45% when PHC279 was applied as a seed treatment. In addition, yields of soybeans were increased by up to 16% when compared with foliar fungicide programs alone.'

'Based on these positive results, Plant Health Care intends to move forward to commercialise PHC279 in Brazil. The company intends to seek a fast track product registration and is making plans to produce PHC279 at commercial scale.'

At 9:41am: (LON:PHC) Plant Health Care PLC share price was +1.03p at 6.78p